Two large trials, DREAM and MENSA have found IL-5 therapy with mepolizumab to lower risk of exacerbation in patients with asthma with an eosinophilic phenotype.
Are intranasal steroids effective in minimizing utilization of antibiotics for acute rhinosinusitis?
A randomized placebo-controlled trial demonstrated that mometasone furoate nasal spray 200 mcg twice daily significantly enhanced minimal symptom days versus amoxicillin or placebo in rhinosinusitis patients aged 12 years and older. This benefit was noted within 2 days and allowed patients to return to activity earlier. The results are promising that inhaled corticosteroid therapy can enhance outcome in rhinosinusitis; while minimizing inappropriate antibiotic use.
Meltzer EO, Gates D, Bachert C, et al: Mometasonefuroate nasal spray increases the number of minimalsymptom days in patients with acute rhinosinusitis.Ann Allergy Asthma Immunol. 2012;108:275-279.
You Might Also Enjoy...
Two large trials, DREAM and MENSA have found IL-5 therapy with mepolizumab to lower risk of exacerbation in patients with asthma with an eosinophilic phenotype.
Mold allergy is difficult to diagnose due to lack of standardized test material.
The current standard for diagnosis of Eosinophilic Esophagitis (EoE) is endoscopy with esophageal biopsy to determine the eosinophil count
Skin prick testing and serum IgE measurement are limited in their ability to predict positive or negative responses to oral peanut challenge.
Bronchial Thermoplasty (BT) has been shown to result in significant improvements in a number of asthma control measures in three randomized clinical trials in patients with moderate-to-severe, persistent asthma.
Recent studies have suggested that early regular exposure to allergenic foods may reduce the risk of food allergy.